組織蛋白酶K(CTSK)多克隆抗體
Polyclonal Antibody to Cathepsin K (CTSK)
CTS-K; CTS02; CTSO; CTSO1; CTSO2; PKND; PYCD; Pycnodysostosis; Cathepsin O; Cathepsin X
- 編號PAA267Ca01
- 物種Canis familiaris; Canine (Dog，犬)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原RPA267Ca01-組織蛋白酶K(CTSK)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種Homo sapiens (Human，人), Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠)
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 648¥ 1512¥ 2160¥ 5400¥ 21600
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
DAB staining on IHC-P; Sample: Human Breast cancer Tissue; Primary Ab: 20ug/ml Rabbit Anti-Canine CTSK Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
DAB staining on IHC-P;
Sample: Human Liver cancer Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Canine CTSK Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
Secondary antibody only control: Used PBS instead of primary antibody, Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Sample: Human Lung cancer Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Canine CTSK Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
Secondary antibody only control: Used PBS instead of primary antibody, Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
Figure. Western Blot; Sample: Recombinant CTSK, Canine.
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對CTSK的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別CTSK。
用法
Western blotting: 0.5-5μg/mL;
Immunohistochemistry: 5-50μg/mL;
Immunocytochemistry: 5-50μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Canis familiaris; Canine (Dog，犬) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA267Ca01 | 組織蛋白酶K(CTSK)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA267Ca01 | 組織蛋白酶K(CTSK)多克隆抗體 | WB; IHC; ICC; IP. |
參考文獻
| 雜志 | 參考文獻 |
| Acta Histochemica | MRMT-1 rat breast carcinoma cells and models of bone metastases: improvement of an in vitro system to mimic the in vivo condition.[PubMed: S0065128112000773] |
| Atherosclerosis.? | Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery[Pubmed:24534452] |
| Genet. Mol. Res | Drynaria total flavonoids decrease cathepsin K expression in ovariectomized rats[Pubmed:25036175] |
| Age (Dordr) | In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytes[PubMed: 26250906] |
| Journal of Infectious Diseases | Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis[PubMed: 26416658] |
| PLoS One. | Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis[pmc:PMC4822855] |
| Cell?Death?And Differentiation | TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42[Pubmed:29358671] |
| Indian Journal of Dental Research | Comparative evaluation of cathepsin K levels in gingival crevicular fluid among smoking and nonsmoking patients with chronic periodontitis[Pubmed: 30409937] |
| International Journal of Biological Macromolecules | A bioactive exopolysaccharide from marine bacteria Alteromonas sp. PRIM-28 and its role in cell proliferation and wound healing in vitro[Pubmed: 30851325] |
| 畢業(yè)論文 | Biomarkers of Compromised Implant Fixation[] |
| neuroscience letters | Compound K induces neurogenesis of neural stem cells in thrombin induced nerve injury through LXRα signaling in mice[Pubmed: 32371156] |
| Информационный алгоритм неинвазивной оценки остеорезорбтивного побочного действия глюкокортикостероидов у больных язвенным колитом[] | |
| Особенности остеоиммунологических аспектов остеорезорбции при периимплантите, хроническом пародонтите и раке альвеолярного отростка и?…[] |